Resources Contact Us Home
Purine derivatives as A3 and A1 adenosine receptor agonists

Image Number 5 for United States Patent #7825126.

Disclosed are (N)-methanocarba adenine nucleosides of the formula: ##STR00001## as highly potent A.sub.3 adenosine receptor agonists, pharmaceutical compositions comprising such nucleosides, and a method of use of these nucleosides, wherein R.sub.1-R.sub.6 are as defined in the specification. These nucleosides are contemplated for use in the treatment a number of diseases, for example, inflammation, cardiac ischemia, stroke, asthma, diabetes, and cardiac arrhythmias. The invention also provides compounds that are agonists of both A.sub.1 and A.sub.3 adenosine receptors for use in cardioprotection.

  Recently Added Patents
Apparatus for controllable delay cell and associated methods
Systems and methods for vehicle cruise control
Adaptive non-positive inductor current detector (ANPICD)
Method for producing lactamates by way of thin film evaporation
Integrated emergency medical database system
Display apparatus, a method for a display control, and program
Multi display device and method of controlling the same
  Randomly Featured Patents
Method and apparatus for component carrier aggregation in wireless communications
Heat treating apparatus and method
Compensating transmission line to reduce sensitivity of performance due to channel length variation
Method of fabricating a non-volatile memory
Automated multiple data unit transfers between a host device and a storage medium
Tire rim with horse design
Camera vibration correction apparatus
Adjustable steering column for motor vehicle
Detachable crane- or boom-operated heat exchanger tube bundle extractor
Vehicle body hinge